BRAIN Biotech AG 0RFI.L Stock
BRAIN Biotech AG Price Chart
BRAIN Biotech AG 0RFI.L Financial and Trading Overview
| BRAIN Biotech AG stock price | 3.2 EUR |
| Previous Close | 5.9 EUR |
| Open | 0 EUR |
| Bid | 0 EUR x 0 |
| Ask | 0 EUR x 0 |
| Day's Range | 0 - 0 EUR |
| 52 Week Range | 0 - 7.26 EUR |
| Volume | 57.11K EUR |
| Avg. Volume | 2.91K EUR |
| Market Cap | 951.61K EUR |
| Beta (5Y Monthly) | 1.410344 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.369 EUR |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
0RFI.L Valuation Measures
| Enterprise Value | 110.55M EUR |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 0.01754835 |
| Price/Book (mrq) | 4.5818815 |
| Enterprise Value/Revenue | 2.039 |
| Enterprise Value/EBITDA | -28.963 |
Trading Information
BRAIN Biotech AG Stock Price History
| Beta (5Y Monthly) | 1.410344 |
| 52-Week Change | -23.54% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 7.26 EUR |
| 52 Week Low | 0 EUR |
| 50-Day Moving Average | 6.08 EUR |
| 200-Day Moving Average | 6.08 EUR |
0RFI.L Share Statistics
| Avg. Volume (3 month) | 2.91K EUR |
| Avg. Daily Volume (10-Days) | 3.19K EUR |
| Shares Outstanding | 18.06M |
| Float | 10.09M |
| Short Ratio | N/A |
| % Held by Insiders | 57.43% |
| % Held by Institutions | 24.75% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | N/A |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | September 30, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | September 30, 2023 |
Profitability
| Profit Margin | -13.70% |
| Operating Margin (ttm) | -13.062% |
| Gross Margin | 52.89% |
| EBITDA Margin | -7.038% |
Management Effectiveness
| Return on Assets (ttm) | -5.67% |
| Return on Equity (ttm) | -22.12% |
Income Statement
| Revenue (ttm) | 54.23M EUR |
| Revenue Per Share (ttm) | 2.48 EUR |
| Quarterly Revenue Growth (yoy) | 2.90% |
| Gross Profit (ttm) | 27.61M EUR |
| EBITDA | -3817000 EUR |
| Net Income Avi to Common (ttm) | -7432000 EUR |
| Diluted EPS (ttm) | -0.369 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 9.16M EUR |
| Total Cash Per Share (mrq) | 0.42 EUR |
| Total Debt (mrq) | 0 EUR |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 1.373 |
| Book Value Per Share (mrq) | 1.148 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -5980000 EUR |
| Levered Free Cash Flow (ttm) | 4.4M EUR |
Profile of BRAIN Biotech AG
| Country | United Kingdom |
| State | N/A |
| City | Zwingenberg |
| Address | Darmstädter Strasse 34-36 |
| ZIP | 64673 |
| Phone | 49 62 51 9331 0 |
| Website | https://www.brain-biotech.com |
| Industry | |
| Sector(s) | |
| Full Time Employees | 318 |
BRAIN Biotech AG offers Bio-based products and solutions in Germany, the United States, France, the Netherlands, and the United Kingdom. The company operates in two segments, BioScience and BioIndustrial. It offers enzymes and biocatalysts to produce food and beverages, wound care preparations or lubricants, and production of starch and bioethanol; bioactive natural compounds for product developments in the food, animal feed, skin care, chemical, and cosmetics industries; and microorganisms as the functional biomass for optimized industrial production processes, recycling of the greenhouse gas CO2 as an industrial raw material, and urban and green mining for extraction of precious and rare earth metals. The company also offers R&D services for contract research for product development and innovative solutions in the categories of enzymes, microbial production strains, and bioprocesses. The company was formerly known as B.R.A.I.N. Biotechnology Research and Information Network AG and changed its name to BRAIN Biotech AG in April 2021. BRAIN Biotech AG was founded in 1993 and is headquartered in Zwingenberg, Germany.
Q&A For BRAIN Biotech AG Stock
What is a current 0RFI.L stock price?
BRAIN Biotech AG 0RFI.L stock price today per share is 3.2 EUR.
How to purchase BRAIN Biotech AG stock?
You can buy 0RFI.L shares on the LSE exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for BRAIN Biotech AG?
The stock symbol or ticker of BRAIN Biotech AG is 0RFI.L.
How many shares does BRAIN Biotech AG have in circulation?
The max supply of BRAIN Biotech AG shares is 180.92K.
What is BRAIN Biotech AG Price to Earnings Ratio (PE Ratio)?
BRAIN Biotech AG PE Ratio is now.
What was BRAIN Biotech AG earnings per share over the trailing 12 months (TTM)?
BRAIN Biotech AG EPS is -0.369 EUR over the trailing 12 months.